Expectations trend
FY2028 · fiscal year ending 2028-02-01 · fmp
Everpure (P)
NYSEInformation TechnologyComputer HardwareSnapshot 2026-11-04
$111.77-5.00%
Close 2026-11-04 · 1-day change
NYSEInformation TechnologyComputer HardwareSnapshot 2026-11-04
The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.
Next-FY EPS estimate change · 30 days
4.19 → 4.19 EPS · FY ending Feb 1, 2028 · 13 analysts
One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.
Change in the same fiscal period’s mean EPS estimate from Oct 5, 2026 to Nov 4, 2026: (new ÷ prior − 1). Contributor count changed from 13 to 13; this is not the number of analysts revising. The ±10% axis is a display range.
The EPS and P/E reference is not available for P yet.
| Measure / period | Management expectations | Analyst expectations |
|---|
Management figures unavailable.
Current consensus figures unavailable.
Three published thesis conditions, with dated milestones shown separately.
| Key Factor | Why It Matters | Current Status | Break Condition | Latest Evidence |
|---|---|---|---|---|
FY27 operating margin near 32.5% | A primary condition in Everpure's published investment case. The stated target is >= 29%. | Improving | FY27 operating margin falls below 29% | Operating margin: 5.33% FY2027-Q2; GAAP. Published target: >= 29%. Annual target cannot be compared with a quarterly or TTM observation. Sep 4, 20265.3255 percent · calculatedLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Compare these dated observations with the operating requirements above
FY2028 · fiscal year ending 2028-02-01 · fmp
The evidence, the remaining questions, and what comes next
No recovery evidence is reported in the available driver assessments.
Nov 18, 2026
Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.
Observed price history; separate from operating scenarios
The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.
P is a high-growth technology business with improving operating results, but it is not yet consistently profitable. Its long-term thesis is intact this month: recent momentum has strengthened and management is delivering on stated priorities, though overall risk remains elevated.
P is expensive versus peers, with a valuation premium and low confidence in the valuation assessment. The evidence labels the priced-in setup unjustified, but does not point to broad fragility beyond the expensive valuation itself.
Near term, recent results show strong revenue growth, revenue above quarterly guidance, and higher FY27 revenue and operating income guidance. Management’s stated priorities are on track, although the business remains loss-making overall and recent peer misses make execution worth watching.
The multi-year view depends on continued revenue growth and progress toward better operating performance. Near term, a guidance cut would be a meaningful negative, while easing rates or steadier results from major technology peers could support the sector backdrop.
For the next 1 to 3 years, P combines improving execution with an expensive valuation, loss-making status, and elevated risk. The thesis remains intact, but depends on management sustaining growth and improving profitability. Not investment advice.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
| A supporting condition in Everpure's published investment case. The stated target is between $1.095 billion and $1.105 billion. |
| Intact |
| Q2 FY27 revenue falls below $1.095 billion |
Revenue: $1.186B FY2027-Q2; GAAP. Published target: between $1.095 billion and $1.105 billion. Target period is not explicitly aligned with this observation. Sep 4, 20261,185,898,000 USD · source valueLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
FY27 revenue at least $4.41 billion | A primary condition in Everpure's published investment case. The stated target is >= $4.41 billion. | Intact | FY27 revenue falls below $4.41 billion | Revenue: $1.186B FY2027-Q2; GAAP. Published target: >= $4.41 billion. Annual target cannot be compared with a quarterly or TTM observation. Sep 4, 20261,185,898,000 USD · source valueLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.
$3.00 → $4.19 · observed estimates
$5.16B → $6.91B · observed estimates
One fiscal period and provider throughout. At least five contributors are required for each plotted metric; missing coverage stays a gap. Axes show the observed range. Counts measure coverage, not revisions.
| Snapshot | EPS | Revenue | EPS / revenue analysts |
|---|---|---|---|
| 2026-07-24 | $3.00 | $5,160,932,076 | 13 / 15 |
| 2026-07-25 | $3.00 | $5,160,932,076 | 13 / 15 |
| 2026-07-26 | $3.00 | $5,160,932,076 | 13 / 15 |
| 2026-07-27 | $3.00 | $5,160,932,076 | 13 / 15 |
| 2026-07-28 | $3.00 | $5,160,932,076 | 13 / 15 |
| 2026-07-29 | $3.00 | $5,160,932,076 | 13 / 15 |
| 2026-07-30 | $3.00 | $5,160,932,076 | 13 / 15 |
| 2026-07-31 | $3.00 | $5,160,932,076 | 13 / 15 |
| 2026-08-01 | $3.00 | $5,160,932,076 | 13 / 15 |
| 2026-08-02 | $3.00 | $5,160,932,076 | 13 / 15 |
| 2026-08-03 | $3.00 | $5,160,932,076 | 13 / 15 |
| 2026-08-04 | $3.00 | $5,160,932,076 | 13 / 15 |
| 2026-08-05 | $3.00 | $5,160,932,076 | 13 / 15 |
| 2026-08-06 | $3.00 | $5,160,932,076 | 13 / 15 |
| 2026-08-07 | $3.00 | $5,160,932,076 | 13 / 15 |
| 2026-08-08 | $3.00 | $5,160,932,076 | 13 / 15 |
| 2026-08-09 | $3.00 | $5,160,932,076 | 13 / 15 |
| 2026-08-10 | $3.00 | $5,160,932,076 | 13 / 15 |
| 2026-08-12 | $3.00 | $5,160,932,076 | 13 / 15 |
| 2026-08-13 | $3.00 | $5,160,932,076 | 13 / 15 |
| 2026-08-14 | $3.00 | $5,160,932,076 | 13 / 15 |
| 2026-08-15 | $3.00 | $5,160,932,076 | 13 / 15 |
| 2026-08-16 | $3.00 | $5,160,932,076 | 13 / 15 |
| 2026-08-17 | $3.00 | $5,160,932,076 | 13 / 15 |
| 2026-08-18 | $3.00 | $5,160,932,076 | 13 / 15 |
| 2026-08-19 | $3.00 | $5,160,932,076 | 13 / 15 |
| 2026-08-20 | $3.07 | $5,215,005,549 | 13 / 15 |
| 2026-08-21 | $3.07 | $5,222,947,655 | 13 / 15 |
| 2026-08-22 | $3.09 | $5,242,952,918 | 13 / 15 |
| 2026-08-23 | $3.09 | $5,242,952,918 | 13 / 15 |
| 2026-08-24 | $3.09 | $5,242,952,918 | 13 / 15 |
| 2026-08-25 | $3.09 | $5,242,952,918 | 13 / 15 |
| 2026-08-26 | $3.09 | $5,242,952,918 | 13 / 15 |
| 2026-08-27 | $3.09 | $5,242,952,918 | 13 / 15 |
| 2026-08-28 | $3.09 | $5,242,952,918 | 13 / 15 |
| 2026-08-29 | $3.55 | $6,137,431,051 | 13 / 15 |
| 2026-08-30 | $3.55 | $6,137,431,051 | 13 / 15 |
| 2026-08-31 | $3.55 | $6,137,431,051 | 13 / 15 |
| 2026-09-01 | $3.55 | $6,137,431,051 | 13 / 15 |
| 2026-09-02 | $3.55 | $6,182,062,630 | 13 / 15 |
| 2026-09-03 | $3.55 | $6,182,062,630 | 13 / 15 |
| 2026-09-04 | $3.55 | $6,182,062,630 | 13 / 15 |
| 2026-09-05 | $3.55 | $6,182,064,709 | 13 / 15 |
| 2026-09-06 | $3.55 | $6,182,064,709 | 13 / 15 |
| 2026-09-07 | $3.55 | $6,182,064,709 | 13 / 15 |
| 2026-09-08 | $3.55 | $6,182,064,709 | 13 / 15 |
| 2026-09-09 | $3.55 | $6,182,064,709 | 13 / 15 |
| 2026-09-10 | $3.55 | $6,182,064,709 | 13 / 15 |
| 2026-09-11 | $3.55 | $6,182,064,709 | 13 / 15 |
| 2026-09-12 | $3.55 | $6,182,064,709 | 13 / 15 |
| 2026-09-13 | $3.55 | $6,182,064,709 | 13 / 15 |
| 2026-09-14 | $3.55 | $6,182,064,709 | 13 / 15 |
| 2026-09-15 | $3.55 | $6,182,064,709 | 13 / 15 |
| 2026-09-16 | $3.55 | $6,182,064,709 | 13 / 15 |
| 2026-09-17 | $3.55 | $6,182,064,709 | 13 / 15 |
| 2026-09-18 | $3.55 | $6,182,064,709 | 13 / 15 |
| 2026-09-19 | $3.55 | $6,182,064,709 | 13 / 15 |
| 2026-09-20 | $3.55 | $6,185,057,709 | 13 / 15 |
| 2026-09-21 | $3.55 | $6,185,057,709 | 13 / 15 |
| 2026-09-22 | $3.55 | $6,185,057,709 | 13 / 15 |
| 2026-09-23 | $3.55 | $6,185,057,709 | 13 / 15 |
| 2026-09-24 | $3.55 | $6,185,057,709 | 13 / 15 |
| 2026-09-25 | $4.17 | $6,834,221,644 | 13 / 14 |
| 2026-09-26 | $4.19 | $6,914,451,386 | 13 / 14 |
| 2026-09-27 | $4.19 | $6,914,451,386 | 13 / 12 |
| 2026-09-28 | $4.19 | $6,914,451,386 | 13 / 12 |
| 2026-09-29 | $4.19 | $6,914,451,386 | 13 / 12 |
| 2026-09-30 | $4.19 | $6,914,451,386 | 13 / 12 |
| 2026-10-01 | $4.19 | $6,914,451,386 | 13 / 13 |
| 2026-10-02 | $4.19 | $6,914,451,386 | 13 / 13 |
| 2026-10-03 | $4.19 | $6,914,451,386 | 13 / 13 |
| 2026-10-04 | $4.19 | $6,914,451,386 | 13 / 13 |
| 2026-10-05 | $4.19 | $6,914,435,596 | 13 / 13 |
| 2026-10-06 | $4.19 | $6,914,451,386 | 13 / 13 |
| 2026-10-07 | $4.19 | $6,914,451,386 | 13 / 13 |
| 2026-10-08 | $4.19 | $6,914,451,386 | 13 / 13 |
| 2026-10-09 | $4.19 | $6,914,451,386 | 13 / 13 |
| 2026-10-10 | $4.19 | $6,914,451,386 | 13 / 13 |
| 2026-10-11 | $4.19 | $6,914,451,386 | 13 / 13 |
| 2026-10-12 | $4.19 | $6,914,451,386 | 13 / 13 |
| 2026-10-13 | $4.17 | $6,911,214,544 | 12 / 13 |
| 2026-10-14 | $4.17 | $6,911,214,544 | 12 / 13 |
| 2026-10-15 | $4.17 | $6,911,214,544 | 13 / 13 |
| 2026-10-16 | $4.17 | $6,911,214,544 | 13 / 13 |
| 2026-10-17 | $4.17 | $6,911,214,544 | 13 / 13 |
| 2026-10-18 | $4.17 | $6,911,214,544 | 13 / 13 |
| 2026-10-19 | $4.17 | $6,911,214,544 | 13 / 13 |
| 2026-10-20 | $4.19 | $6,911,198,754 | 13 / 13 |
| 2026-10-21 | $4.19 | $6,911,198,754 | 13 / 13 |
| 2026-10-22 | $4.19 | $6,911,198,754 | 13 / 13 |
| 2026-10-23 | $4.19 | $6,911,198,754 | 13 / 13 |
| 2026-10-24 | $4.19 | $6,911,198,754 | 13 / 13 |
| 2026-10-25 | $4.19 | $6,911,198,754 | 13 / 13 |
| 2026-10-26 | $4.19 | $6,911,198,754 | 13 / 13 |
| 2026-10-27 | $4.19 | $6,911,198,754 | 13 / 13 |
| 2026-10-28 | $4.19 | $6,911,198,754 | 13 / 13 |
| 2026-10-29 | $4.19 | $6,911,198,754 | 13 / 14 |
| 2026-10-30 | $4.19 | $6,911,198,754 | 13 / 14 |
| 2026-10-31 | $4.19 | $6,911,198,754 | 13 / 14 |
| 2026-11-01 | $4.19 | $6,911,198,754 | 13 / 14 |
| 2026-11-02 | $4.19 | $6,911,198,754 | 13 / 14 |
| 2026-11-03 | $4.19 | $6,911,198,754 | 13 / 14 |
| 2026-11-04 | $4.19 | $6,911,198,754 | 13 / 14 |
Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.
Latest: 18 Buy / Strong Buy · 1 Hold · 1 Sell / Strong Sell
Recent actions · Oct 6–Nov 4 · 2 recorded
2 raises · 0 cuts · 0 unchanged · 0 without a comparable prior
Oct 6, 2026–Nov 4, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.
3 of 3 published conditions remain under pressure or need verification. The next results need to address those conditions.
The dated weekly assessment and its assumptions are available in Read detailed Outlook.